FDA Issues Class I Recall for Medline Homecare Beds Over Fire and Shock Hazards

BenzingaBenzinga
|||1 min read
Key Takeaway

FDA issues Class I recall for Medline homecare beds due to fire and electrical shock hazards. One death linked to overheating cords; company distributing revised instructions instead of removal.

FDA Issues Class I Recall for Medline Homecare Beds Over Fire and Shock Hazards

The Food and Drug Administration has classified a safety issue with Medline's Basic Homecare Beds as a Class I recall, the most serious category, citing electrical hazards that pose risks of fire and electrical shock to patients. Rather than removing the beds from circulation, Medline has opted to distribute revised operating instructions to address the identified safety concerns.

The recall encompasses multiple safety issues documented through December 18. The agency has linked 12 injuries and one death to overheating pendant cords, while two additional injuries and one death have been attributed to patient entrapment hazards involving non-Medline accessories used with the beds. These incidents underscore the potential severity of the electrical and mechanical defects identified in the product.

Class I recalls indicate situations where there is a reasonable probability that exposure to the defective product will cause serious adverse health consequences or death. The FDA's classification reflects the gravity of the documented safety risks associated with the Medline homecare beds, particularly given the vulnerable patient population that relies on such equipment.

Source: Benzinga

Back to newsPublished Feb 13

Related Coverage

Benzinga

FDA Issues Highest-Risk Recall of Insulet's Omnipod 5 Over Insulin Delivery Defects

FDA classifies Insulet's Omnipod 5 recall as highest-risk due to insulin under-delivery defects. Stock plunges 10.95% amid 476 reported serious injuries.

PODD
Benzinga

FDA Issues Class I Recall for Tandem Diabetes Mobi Pumps Over Insulin Delivery Risk

FDA classifies Class I recall for Tandem Diabetes' Mobi insulin pumps due to false motor failure detection risking insulin delivery interruption.

TNDM
Benzinga

FDA Issues Warning Letter to Medline Over Critical Quality System Failures at NY Facility

FDA flags Medline for quality lapses at New York facility producing angiographic syringes, citing manufacturing deficiencies and inadequate response to 221 complaints.

MDLN
GlobeNewswire Inc.

Roblox, Discord, Snap Face Federal Lawsuit Over Alleged Minor Exploitation Design Flaws

Philadelphia law firm sues $ROBLOX, $SNAP, Discord alleging platform designs enabled sexual exploitation of minor through inadequate safety measures.

SNAPRBLX
Benzinga

FDA Issues Safety Alert Over Intuitive Surgical Stapler Failures in da Vinci System

FDA alerts to safety defects in Intuitive Surgical's da Vinci staplers causing incomplete staple lines, one death, and four injuries. Company directs hospitals to remove affected devices immediately.

ISRG
Benzinga

Soleno Therapeutics Faces Securities Fraud Lawsuit Over DCCR Safety Claims

Class action lawsuit filed against $SLNO over alleged securities fraud tied to DCCR drug safety concerns, patient death, and disappointing Q3 results.

SLNO